BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND PBX1, P40424, 5087 AND Prognosis
86 results:

  • 1. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. [Clinical Significance of Minimal Residual Disease in Pediatric Patients with
    Xue YJ; Lu AD; Wang Y; Jia YP; Zuo YX; Zhang LP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Oct; 31(5):1303-1308. PubMed ID: 37846676
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Clinical features and prognosis of high hyperdiploid childhood acute lymphoblastic leukemia: a multicenter retrospective analysis in Fujian Province, China].
    Cai CX; Zheng YZ; Li J; Wen H; Weng KZ; Zhuang SQ; Wu XG; LE SH
    Zhongguo Dang Dai Er Ke Za Zhi; 2023 Jan; 25(1):38-45. PubMed ID: 36655662
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Cytogenetic Profile Of Acute Lymphoblastic Leukaemia Patients And Its Association With Induction Remission Status.
    Niaz H; Malik HS; Mahmood R; Mehmood A; Nisar U; Jalil S
    J Ayub Med Coll Abbottabad; 2022; 34(Suppl 1)(4):S909-S912. PubMed ID: 36550642
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Detection of Fusion Gene and prognosis Analysis in Children with Acute Lymphoblastic Leukemia of Different Immunophenotypes].
    Liu CY; Pan YS; Yang H; Hu X; Chen HY; Liu WJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Dec; 30(6):1673-1678. PubMed ID: 36476888
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.
    Kulis J; Sędek Ł; Słota Ł; Perkowski B; Szczepański T
    Genes (Basel); 2022 Jul; 13(8):. PubMed ID: 36011285
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Clinical features and prognosis of childhood B-lineage acute lymphoblastic leukemia expressing the
    Zhang F; Lu AD; Zuo YX; Ding MM; Jia YP; Zhang LP
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 May; 24(5):543-549. PubMed ID: 35644195
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Association of Genetic Ancestry With the Molecular Subtypes and prognosis of Childhood Acute Lymphoblastic Leukemia.
    Lee SHR; Antillon-Klussmann F; Pei D; Yang W; Roberts KG; Li Z; Devidas M; Yang W; Najera C; Lin HP; Tan AM; Ariffin H; Cheng C; Evans WE; Hunger SP; Jeha S; Mullighan CG; Loh ML; Yeoh AEJ; Pui CH; Yang JJ
    JAMA Oncol; 2022 Mar; 8(3):354-363. PubMed ID: 35084434
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Cytogenetic Characteristics of Childhood Acute Lymphoblastic Leukemia: A Study of 1541 Chinese Patients Newly Diagnosed between 2001 and 2014.
    Yin MM; Wu RC; Gao J; Hu SY; Liu XM; Zhu XF; Shen SH; Tang JY; Chen J; Hu Q
    Curr Med Sci; 2022 Feb; 42(1):201-209. PubMed ID: 34874488
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Clonal dynamics in pediatric B-cell precursor acute lymphoblastic leukemia with very early relapse.
    Antić Ž; Yu J; Bornhauser BC; Lelieveld SH; van der Ham CG; van Reijmersdal SV; Morgado L; Elitzur S; Bourquin JP; Cazzaniga G; Eckert C; Camós M; Sutton R; Cavé H; Moorman AV; Sonneveld E; Geurts van Kessel A; van Leeuwen FN; Hoogerbrugge PM; Waanders E; Kuiper RP
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29361. PubMed ID: 34597466
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/TCF3-pbx1 treated with measurable residual disease-oriented protocols.
    Ribera J; Granada I; Morgades M; González T; Ciudad J; Such E; Calasanz MJ; Mercadal S; Coll R; González-Campos J; Tormo M; García-Cadenas I; Gil C; Cervera M; Barba P; Costa D; Ayala R; Bermúdez A; Orfao A; Ribera JM;
    Br J Haematol; 2022 Feb; 196(3):670-675. PubMed ID: 34549416
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
    Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-pbx1: A 10-year retrospective study.
    Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
    Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Efficacy and safety of induction chemotherapy with daunorubicin or idarubicin in the treatment of an adult with acute lymphoblastic leukemia.
    Zhang Q; Zhang CH; Wang ZD; Wang D
    Tumori; 2022 Apr; 108(2):182-188. PubMed ID: 34296648
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expression of BCL6 in paediatric B-cell acute lymphoblastic leukaemia and association with prognosis.
    Mäkinen A; Nikkilä A; Mehtonen J; Teppo S; Oksa L; Nordlund J; Rounioja S; Pohjolainen V; Laukkanen S; Heinäniemi M; Paavonen T; Lohi O
    Pathology; 2021 Dec; 53(7):875-882. PubMed ID: 34049715
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical features and prognostic impact of TCF3-pbx1 in childhood acute lymphoblastic leukemia: A single-center retrospective study of 837 patients from China.
    Jia M; Hu BF; Xu XJ; Zhang JY; Li SS; Tang YM
    Curr Probl Cancer; 2021 Dec; 45(6):100758. PubMed ID: 34034913
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The role of minimal residual disease in specific subtypes of pediatric acute lymphoblastic leukemia.
    Xue YJ; Wang Y; Jia YP; Zuo YX; Wu J; Lu AD; Zhang LP
    Int J Hematol; 2021 Apr; 113(4):547-555. PubMed ID: 33386596
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. [Clinical significance of minimal residual disease in B-lineage acute lymphoblastic leukemia pediatric patients with different fusion gene backgrounds].
    Wei T; Chen XJ; Zhang LY; Zhang AL; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 Dec; 22(12):1279-1285. PubMed ID: 33327998
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. [The Correlation of Minimal Residual Disease with prognosis in TCF3-pbx1
    Zhang L; Zou Y; Ai XF; Cao Z; Chen YM; Guo Y; Yang WY; Chen XJ; Wang SC; Liu XM; Ruan M; Liu TF; Liu F; Qi BQ; Chang LX; An WB; Ren YY; Li QH; Zhu XF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Dec; 28(6):1831-1836. PubMed ID: 33283706
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 5.